Revealing the cost of Type II diabetes in Europe
- 3.5k Downloads
‘The Cost of Diabetes in Europe-Type II study’ is the first coordinated attempt to measure total healthcare costs of Type II (non-insulin-dependent) diabetes mellitus in Europe. The study evaluated more than 7000 patients with Type II diabetes in eight countries — Belgium, France, Germany, Italy, the Netherlands, Spain, Sweden and the United Kingdom.
A bottom-up, prevalence-based design was used, which optimised the collection of data at the national level while maintaining maximum international comparability. Effort was made to ensure consistency in terms of data specification, data collection tools and methods, sampling design, and the analysis and reporting of results. Results are reported for individual countries and in aggregate for the total study population.
The total direct medical costs of Type II diabetes in the eight European countries was estimated at EUR 29 billion a year (1999 values). The estimated average yearly cost per patient was EUR 2834 a year. Of these costs, hospitalisations accounted for the greatest proportion (55%, range 30-65%) totalling EUR 15.9 billion for the eight countries. During the 6-month evaluation period, 13% of the Type II diabetic patients were hospitalised, with an average of 23 days in hospital projected annually. In contrast, drug costs for managing Type II diabetes were relatively low, with antidiabetic drugs and insulin accounting for only 7% of the total healthcare costs for Type II diabetes.
Type II diabetes mellitus is a common disease and the prevalence is expected to increase considerably in the future, especially in developing countries. Current comprehensive economic data on the costs of diabetes are required for policy decisions to optimise resource allocation and to evaluate different approaches for disease management.
Cost of diabetes in Europe — Type II
health-related quality of life
international classification of diseases
intensive care unit
organization for economic co-operation and development
- 1.McCarty D, Zimmet P (1994) Diabetes 1994 to 2010: global estimates and projections. International Diabetes Institute, MelbourneGoogle Scholar
- 3.King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevelance, numerical estimates, and projections. Diabetes Care 21:1414–1431Google Scholar
- 4.Ray N, Willis S, Thamer M (1993) Direct and indirect costs of diabetes in the United States in 1992. American Diabetes Association, AlexandriaGoogle Scholar
- 5.Harris MI, Flegal KM, Cowie CC et al. (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518–524Google Scholar
- 8.Organization for Economic Cooperation and Development (1990) Health care systems in transition; the search for efficiency. Organization for Economic Cooperation and Development (OECD) Social Policy Studies No. 7. Paris pp 129–135Google Scholar
- 9.Laing W, Williams R (1989) Diabetes: a model for health care management. Office of Health Economics, LondonGoogle Scholar
- 13.Jönsson B (1983) Diabetes — the cost of illness and the cost of control. Acta Med Scand 671 [Suppl]: 19–27Google Scholar
- 15.Marks L (1996) Counting the Cost — The real impact of non-insulin dependent diabetes. Kings Fund Report com-missioned by the British Diabetic Association, LondonGoogle Scholar
- 16.Laing W, Williams R (1989) Diabetes: a model for health care management. No 92 in a series of papers on current health problems. Office of Health Economics, LondonGoogle Scholar
- 17.Koopmanschap M (2002) Coping with Type 2 diabetes: the patient perspective. Diabetologia supplement (this issue)Google Scholar
- 19.Williams R, Van Gaa L, Lucioni C (2002) Assessing the impact of complications on the costs of Type 2 diabetes. Diabetologia supplement (this issue)Google Scholar
- 20.Gesundheitsbericht für Deutschland (1998) Statistisches Bundesamt, Gesundheitsberichterstattung des Bundes, Metzler-Poeshel, StuttgartGoogle Scholar
- 21.Vaccaro O, Bonora E, Bruno G, Garancini MP, Muntoni S (1996) L’epidemiologia del diabete non-insulino-dipendente e delia ridotta tolleranza al glucosio II diabete in Italia. Kurds Milano, pp 17–30Google Scholar
- 22.Baan CA, Bonneux L, Ruwaard D, Feskens EJM (1998) The prevalence of diabetes mellitus in the Netherlands. A quantitative review. Eur J Public Health:210–216Google Scholar
- 23.The Regional Autonomous Government of Catalunya (1997) Prevalenca de diabetis mellitus no insulinodependent a Catalunya. Bulleti Epidemiologic de Catalunya. Conseil Asesor sobre la Diabetis e Catalunya Vol 18, No. 3, Department de Sanitat i Seguretat Social CatalunyaGoogle Scholar
- 25.Organization for Economic Cooperation and Development (2000) OECD Health data 00 CD ROM. Organization for Economic Cooperation and Development, ParisGoogle Scholar